\r\nCEO/EVP: Donald Anderson \r\nCorp. Offices: Sun Prairie, Wis. \r\nNumber of Members: 3,300 \r\nWeb page: www.ipcrx.com \r\n \r","showSummary":null,"url":"/pharmacy/ipc-taps-pbm-expertise-new-leadership","date":"2009-03-29T00:00:00","author":{"email":null,"uname":"Anonymous","firstName":null,"lastName":null,"bio":null,"title":null,"picture":null,"phone":null,"contactForm":null},"digitalEdition":null,"sponsored":false,"taggedPro":null,"teaserImage":{"id":55893,"url":"https://assets1.drugstorenews.com/styles/secondary_articles_short/s3/teaser_image_352297.jpg?itok=6r38IKp5","width":147,"height":245,"alt":null},"topics":[{"name":"News","url":"/news"},{"name":"RETAIL NEWS","url":"/retail-news"},{"name":"PHARMACY","url":"/pharmacy"},{"name":"Pharmacy Technology","url":"/pharmacy-technology"},{"name":"CVS","url":"/cvs"}],"attachedFiles":[]},{"title":"Walgreens riding out economic storm, propelling surge in chain’s stock price","id":37545,"bundle":"article","summary":"
It could have been so much worse.
\r\n
\r\n
That conclusion, apparently, is what investors drew from Walgreens’ sales and earnings report for the second quarter ended Feb. 28. And it was enough to push the company’s stock price up sharply and burnish the investment outlook for other drug retailers: even Rite Aid’s stock price responded with a nice up-tick.
\r\n
\r\n
","showSummary":null,"url":"/pharmacy/what-it-means-and-why-its-important-walgreens-riding-out-economic-storm-propelling-surge-cha","date":"2009-03-27T00:00:00","author":{"email":null,"uname":"Anonymous","firstName":null,"lastName":null,"bio":null,"title":null,"picture":null,"phone":null,"contactForm":null},"digitalEdition":null,"sponsored":false,"taggedPro":null,"teaserImage":null,"topics":[{"name":"News","url":"/news"},{"name":"RETAIL NEWS","url":"/retail-news"},{"name":"PHARMACY","url":"/pharmacy"},{"name":"WALGREENS","url":"/walgreens"},{"name":"RITE AID","url":"/rite-aid"},{"name":"INSIGHTS AND PERSPECTIVES","url":"/insights-and-perspectives"}],"attachedFiles":[]},{"title":"Drug Fair Group files for bankruptcy","id":36865,"bundle":"article","summary":"
The retail pharmacy universe just got a little bit smaller.
\r\n
\r\n
Despite Drug Fair’s turnaround efforts in recent years, the regional player has fallen victim to the current economic crunch, filing for bankruptcy protection and agreeing to sell the majority of its assets to Walgreens.
NEW YORK — If anyone thinks that CVS has recast itself solely as a healthcare company, given its string of acquisitions in recent years — particularly, Caremark and MinuteClinic — they probably haven’t seen a Beauty360 store yet. In fact, standing in the middle of one of these 3,000 sq.-ft., high-end beauty boutiques, you might have a hard time recognizing you were in a CVS store at all.
NEW YORK Rite Aid has been fighting off the delisting of its shares trading on the New York Stock Exchange since September, and although the company had the approval of its investors to execute a reverse-split in its back pocket, certainly that was a card management didn’t want to play if it could avoid it.
That conclusion, apparently, is what investors drew from Walgreens’ sales and earnings report for the second quarter ended Feb. 28. And it was enough to push the company’s stock price up sharply and burnish the investment outlook for other drug retailers: even Rite Aid’s stock price responded with a nice up-tick.
The retail pharmacy universe just got a little bit smaller.
Despite Drug Fair’s turnaround efforts in recent years, the regional player has fallen victim to the current economic crunch, filing for bankruptcy protection and agreeing to sell the majority of its assets to Walgreens.